PET scan study of BMS-986521 in healthy adults
This study tests a new drug called BMS-986521 using a special brain scan (PET scan) to see how well it attaches to certain receptors in the brain. It is for healthy volunteers to help understand how the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult (male or female at birth) and not able to become pregnant.
- Your body mass index (BMI) must be between 18 and 30 kg/m², and you must weigh at least 110 pounds (50 kg).
- You cannot have any major medical condition, especially involving the brain, heart, kidneys, liver, stomach, hormones, or immune system.
- You cannot have a history of rhabdomyolysis (a muscle breakdown condition).
- You cannot have had a serious stomach or bowel problem in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
This study tests an experimental drug called BMS-986368 in healthy Chinese volunteers to see how the body absorbs and processes it, and to check for any side effects. It helps determine a safe dose for future studies.
This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This trial is testing an investigational drug to see how it moves through the body and how it affects the immune system. It is only for healthy Chinese adults, and results will help guide future studies.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.